89 related articles for article (PubMed ID: 11564549)
21. Interactions of the 4-quinolones with other antibacterials.
Lewin CS; Smith JT
J Med Microbiol; 1989 Jul; 29(3):221-7. PubMed ID: 2664184
[TBL] [Abstract][Full Text] [Related]
22. [Effect of efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine to MIC values of ciprofloxacin in ciprofloxacin resistant gram-negative bacteria].
Coban AY; Bayram Z; Sezgin FM; Durupinar B
Mikrobiyol Bul; 2009 Jul; 43(3):457-61. PubMed ID: 19795621
[TBL] [Abstract][Full Text] [Related]
23. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
[TBL] [Abstract][Full Text] [Related]
24. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
[TBL] [Abstract][Full Text] [Related]
25. [Study of quinolones resistance in Escherichia coli, Staphylococcus aureus and Pseudomonas areuginosa].
Feng P; Yu R; Xia P; Lü X; Zhu S
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):501-4. PubMed ID: 12528531
[TBL] [Abstract][Full Text] [Related]
26. Function of the SOS process in repair of DNA damage induced by modern 4-quinolones.
Howard BM; Pinney RJ; Smith JT
J Pharm Pharmacol; 1993 Jul; 45(7):658-62. PubMed ID: 7692035
[TBL] [Abstract][Full Text] [Related]
27. In vitro pharmacodynamic properties of a fluoroquinolone pharmaceutical derivative: hydrochloride of ciprofloxacin-aluminium complex.
Alovero FL; Olivera ME; Manzo RH
Int J Antimicrob Agents; 2003 May; 21(5):446-51. PubMed ID: 12727078
[TBL] [Abstract][Full Text] [Related]
28. Lethal action of quinolones against a temperature-sensitive dnaB replication mutant of Escherichia coli.
Zhao X; Malik M; Chan N; Drlica-Wagner A; Wang JY; Li X; Drlica K
Antimicrob Agents Chemother; 2006 Jan; 50(1):362-4. PubMed ID: 16377712
[TBL] [Abstract][Full Text] [Related]
29. Influence of human urine on the in vitro activity and postantibiotic effect of ciprofloxacin against Escherichia coli.
Zhanel GG; Karlowsky JA; Davidson RJ; Hoban DJ
Chemotherapy; 1991; 37(3):218-23. PubMed ID: 1889309
[TBL] [Abstract][Full Text] [Related]
30. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
Eraç B; Gill A; Amyes SG; Gülay Z
Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
[TBL] [Abstract][Full Text] [Related]
31. Lomefloxacin-induced modification of the kinetics of growth of gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils.
Pruul H; McDonald PJ
J Antimicrob Chemother; 1990 Jan; 25(1):91-101. PubMed ID: 2108116
[TBL] [Abstract][Full Text] [Related]
32. Contribution of QnrA, a Plasmid-Mediated Quinolone Resistance Peptide, to Survival of Escherichia coli Exposed to a Lethal Ciprofloxacin Concentration.
Goto K; Kawamura K; Arakawa Y
Jpn J Infect Dis; 2015; 68(3):196-202. PubMed ID: 25672356
[TBL] [Abstract][Full Text] [Related]
33. Bactericidal action of PD127,391, an enhanced spectrum quinolone.
Lewin CS; Amyes SG
J Med Microbiol; 1990 Sep; 33(1):67-70. PubMed ID: 2231674
[TBL] [Abstract][Full Text] [Related]
34. Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center.
Canawati HN; el-Farra R; Seymour J; Shimashita J; Dunn D; Montgomerie JZ
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):133-8. PubMed ID: 9401805
[TBL] [Abstract][Full Text] [Related]
35. A class of gyrase mutants of Salmonella typhimurium show quinolone-like lethality and require rec functions for viability.
Garí E; Figueroa-Bossi N; Blanc-Potard AB; Spirito F; Schmid MB; Bossi L
Mol Microbiol; 1996 Jul; 21(1):111-22. PubMed ID: 8843438
[TBL] [Abstract][Full Text] [Related]
36. Rifampicin and chloramphenicol effects on DNA replication in thymine-prestarved Escherichia coli B/r WP2 thy trp.
Doudney CO
Biochim Biophys Acta; 1978 Nov; 521(1):111-6. PubMed ID: 363154
[TBL] [Abstract][Full Text] [Related]
37. Effects of order of magnesium exposure on the postantibiotic effect and bactericidal activity of ciprofloxacin.
Li RC; Lo KN; Lam JS; Lau PY
J Chemother; 1999 Aug; 11(4):243-7. PubMed ID: 10465124
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between the sensitivity of Pseudomonas aeruginosa and the post-antibiotic effect of sparfloxacin and ciprofloxacin].
Pastor A; Cantón E; Pemán J
Rev Esp Quimioter; 1998 Dec; 11(4):333-8. PubMed ID: 9990147
[TBL] [Abstract][Full Text] [Related]
39. Comparative in vitro activity of a new fluorinated 4-quinolone, QA-241.
Niu WW; Neu HC
Diagn Microbiol Infect Dis; 1989; 12(3):243-51. PubMed ID: 2791486
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of Escherichia coli in the logarithmic and stationary phases of growth.
Zeiler HJ
Antimicrob Agents Chemother; 1985 Oct; 28(4):524-7. PubMed ID: 2934022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
